Health Care (CNBC)

Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.

Health Care (CNBC)

3 hours 5 minutes ago

Checkout news

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.

Health Care (CNBC)

12 hours 35 minutes ago

Checkout news

FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks

The FDA is phasing out the use of petroleum-based synthetic dyes in food and drinks.

Health Care (CNBC)

1 day 16 hours ago

Checkout news

Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Health Care (CNBC)

1 day 19 hours ago

Checkout news

Danaher's quarterly results show signs of life, and the struggling stock soars

Count us among the Danaher investors breathing a sigh of relief.

Health Care (CNBC)

1 day 21 hours ago

Checkout news

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

Health Care (CNBC)

2 days 18 hours ago

Checkout news

These are the 4 biggest things we're watching in the stock market in the week ahead

First-quarter earnings season picks up speed inside our portfolio and outside of it.

Health Care (CNBC)

3 days 18 hours ago

Checkout news

UnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers

The warning sign from a health-care giant seen as the insurance industry's bellwether may mean trouble for companies with Medicare Advantage plans.

Health Care (CNBC)

6 days 19 hours ago

Checkout news

Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival

Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.

Health Care (CNBC)

6 days 21 hours ago

Checkout news

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.

Health Care (CNBC)

6 days 21 hours ago

Checkout news

Eli Lilly shares surge on new obesity pill data. What it means for the stock from here

Jim Cramer said Eli Lilly's new trial data has turned the obesity market into a 'one-horse race.'

Health Care (CNBC)

6 days 22 hours ago

Checkout news

23andMe bankruptcy under congressional investigation for customer data

The House Committee on Energy and Commerce is investigating 23andMe's decision to file for bankruptcy

Health Care (CNBC)

1 week ago

Checkout news

Abbott Labs shares surge on earnings and a big sign of confidence in the business

Abbott's strong stock performance continued Wednesday after a first-quarter earnings beat and a guidance reaffirmation.

Health Care (CNBC)

1 week ago

Checkout news

Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.

Health Care (CNBC)

1 week ago

Checkout news

Medical product manufacturers are divided over Trump's tariffs

Medical technology and device makers are fighting for tariff exemptions, while PPE makers are applauding the levies.

Health Care (CNBC)

1 week ago

Checkout news

CDC says measles cases are most likely underreported as outbreak swells in Texas

The leader of the CDC’s measles team said the agency was “scraping” to find resources to address an outbreak in the Southwest.

Health Care (CNBC)

1 week 1 day ago

Checkout news

Pfizer scraps daily weight loss pill after liver injury in one patient

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giant's bid to win a slice of the booming market for GLP-1s.

Health Care (CNBC)

1 week 3 days ago

Checkout news

UnitedHealth is making struggling doctors repay loans issued after last year's cyberattack

UnitedHealth is aggressively recouping the loans the company offered doctors following the 2024 cyberattack at its Change Healthcare unit.

Health Care (CNBC)

1 week 5 days ago

Checkout news

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

It's unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

Health Care (CNBC)

1 week 5 days ago

Checkout news